Athira Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athira Pharma and other ETFs, options, and stocks.

About ATHA

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. 

CEO
Mark J. Litton
CEOMark J. Litton
Employees
26
Employees26
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
2011
Founded2011
Employees
26
Employees26

ATHA Key Statistics

Market cap
10.00M
Market cap10.00M
Price-Earnings ratio
-0.09
Price-Earnings ratio-0.09
Dividend yield
—
Dividend yield—
Average volume
147.74K
Average volume147.74K
High today
$0.264
High today$0.264
Low today
$0.236
Low today$0.236
Open price
$0.236
Open price$0.236
Volume
33.78K
Volume33.78K
52 Week high
$3.67
52 Week high$3.67
52 Week low
$0.2195
52 Week low$0.2195

People also own

Based on the portfolios of people who own ATHA. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
SNDL
Lucid Group
Workhorse
Plug Power
AMC Entertainment
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.